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A B S T R A C T
A case of a 16-year old adolescent is presented who was referred for investigation of a 
syncopal episode. The ECG displayed a very short QT interval of 280 ms, compatible 
with the newly described short QT syndrome, which is a genetic primary electrical 
disease of abnormal potassium currents responsible for the repolarization process of 
the cardiac muscle. The prognosis is similar to the other well known familial cardiac 
channelopathies, such as the long QT or the Brugada syndromes, which are associ-
ated with a high risk of sudden cardiac death, requiring an implantable cardioverter 
defibrillator device for life-long protection.
A 16-year old adolescent was referred for investigation of a syncopal episode. The 
episode occurred while at an upright position, was preceded by dizziness and was non 
traumatic. There was no seizure activity reported, no tongue-bite or loss of bowel or 
bladder function. Family history was negative for sudden or unexplained deaths. Initial 
work-up was non-revealing. Physical examination was unremarkable. No orthostatic 
blood pressure changes were recorded. Carotid sinus massage was negative. However, 
the ECG displayed a very short QT interval of 280 ms (encircled, Fig. 1), compatible 
with the newly described short QT syndrome. There was also a relative absence of 
the ST segment with the J-point elevated in the lateral leads (early repolarization). 
Echocardiography disclosed no structural cardiac abnormalities. A stress and a tilting 
test to be followed by an electrophysiology study were recommended but the patient 
and his family refused further work-up or treatment. He remained well for the ensuing 
two years, but he was lost to further follow-up. 
●●●
The QT interval on an electrocardiogram encompasses the time required for the 
heart to depolarize and also complete its repolarization. It has been made abundantly 
clear over the years that a long QT interval mostly due to delayed and abnormal 
repolarization, a cardinal feature of the long QT syndromes, predisposes patients 
to life-threatening ventricular arrhythmia (torsades de pointes) and sudden cardiac 
death. The short QT syndrome is a newly recognized disease, first described in 2000,1 
characterized by a shortened QT interval and by episodes of syncope, paroxysmal 
atrial fibrillation or life-threatening arrhythmias. This autosomal dominant syndrome 
usually affects young and otherwise healthy individuals with no underlying structural 
heart disease and may be familial or present in sporadic cases. Over the last decade, 
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3 different genes leading to this disease have been described, 
and treatment has been proposed.2,3 
The ion currents responsible for cardiac depolarization are 
mediated mainly by channels that allow the entry of sodium 
and calcium ions into the cell, while the repolarizing currents 
are mediated by channels that allow the exit of potassium 
ions. The short QT syndrome, as is the case with most primary 
electrical diseases (long QT syndrome, Brugada syndrome, 
catecholaminergic polymorphic ventricular tachycardia) is 
caused by mutations in genes that encode for cardiac ion 
channels participating in repolarization.2-4 To date 3 genes, 
KCNH2 (HERG), KCNQ1 and KCNJ2, encoding different 
repolarizing potassium channels have been detected in this 
syndrome. Although there may be benign variants of QT 
abbreviation, most patients with short QT syndrome have a 
family history of syncope, sudden death or atrial fibrillation. 
The clinical picture is highly variable; individuals afflicted 
by the syndrome may be asymptomatic or report episodes of 
syncope or atrial fibrillation or sustain episodes of ventricular 
tachyarrhythmias which may lead to sudden death. The ECG 
characteristically shows a very short QT interval (<320 ms), 
virtual absence of the ST segment (Fig. 1); and tall, peaked, 
narrow-based T waves. In some patients, as in our case, early 
repolarization has been concurrently noted (Fig. 1).5-7 
For patients with aborted sudden death, or symptomatic 
individuals with syncope or those with a family history of 
sudden death, implantation of a cardioverter-defibrillator 
(ICD) device is the standard treatment. Antiarrhythmic agents 
that prolong the QT interval, such as sotalol or quinidine or 
disopyramide, have been suggested for the first form of the 
syndrome, however, no known potassium blocking agent can 
specifically target the other 2 forms.3,4 This, of course, implies 
that there is a need to identify the form, by either genetic 
screening or by clinical means, so that the right therapy can be 
selected, which is usually not an easy task. Some investigators 
have proposed that early repolarization concomitant with short 
QT interval indicates a potential for sudden cardiac death.5-7 In 
the largest series in the literature of long-term follow-up (over 
5 years) of 53 patients with short QT syndrome, 24 patients 
received an ICD which was effective in preventing sudden 
death, while no arrhythmic events occurred in 12 patients 
receiving hydroquinidine.8
FIguRe 1. See text for discussion. 
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